CSL's slow cure

Article Abstract:

Brian Mcnamee, the managing director of CSL is tackling major challenges of reviving the companies earning and rebuilding investor support. CSL's share prices went up by 40% indicating recovery from the worst period. The recovery is mainly due to the interest shown by international buyers.

Author: Quinlivan, Beth
Commodity & service prices, Drugs, Prices and rates, Stocks, Biological products industry, Company pricing policy, CSL Ltd., Mcnamee, Brian

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cochlear's high note

Article Abstract:

Cochlear Ltd. posted rise in share price by 150% and $221 million revenues for 2006. The business growth is attributed to managerial strategies of chief executive Chris Roberts.

Author: Quinlivan, Beth
Sales, profits & dividends, Medical Instruments and Supplies, Medical Equipment and Supplies Manufacturing, Medical Instruments & Supplies, Company sales and earnings, Growth, Company earnings/profit, Medical equipment and supplies industry, Medical equipment industry, Medical test kit industry, Company growth, Cochlear Ltd., Roberts, Chris

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Management, Australia, Officials and employees, Securities, Company business management, Company securities
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.